General Information of the Compound
Compound ID
CP0439585
Compound Name
2-[4-(1H-Benzoimidazol-2-ylmethyl)-piperazin-1-yl]-benzonitrile
    Show/Hide
Structure
Formula
C19H19N5
Molecular Weight
317.396
Canonical SMILES
N#Cc1ccccc1N1CCN(Cc2nc3ccccc3[nH]2)CC1
    Show/Hide
InChI
InChI=1S/C19H19N5/c20-13-15-5-1-4-8-18(15)24-11-9-23(10-12-24)14-19-21-16-6-2-3-7-17(16)22-19/h1-8H,9-12,14H2,(H,21,22)
    Show/Hide
InChIKey
FXHHMDYNRLYBIP-UHFFFAOYSA-N
Physicochemical Property
logP
2.75678
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
58.95
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9858141
SID: 14821326
ChEMBL ID
CHEMBL340099
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 14.6 nM
   TI
   LI
   LO
   TS